Callan JMB Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CJMB research report →
Price Chart
About the company
Callan JMB Inc. , operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials.
- CEO
- Wayne Williams
- IPO
- 2025
- Employees
- 19
- HQ
- Spring Branch, TX, US
Get TickerSpark's AI analysis on CJMB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.44M
- P/E
- -0.16
- PEG
- 0.01
- P/S
- 0.30
- P/B
- 4.13
- EV/EBITDA
- -0.19
- Div Yield
- 0.00%
- Gross Margin
- 41.94%
- Op Margin
- -150.67%
- Net Margin
- -202.19%
- ROE
- -767.27%
- ROIC
- -282.51%
Latest fiscal year · YoY change
- Revenue
- $5.72M-12.8%
- Gross Profit
- $2.10M-17.9%
- Op Income
- $-6,492,491
- Net Income
- $-7,966,366-247.3%
- EPS
- $-1.82-109.2%
- OCF Growth
- -941.4%
- FCF Growth
- -1144.9%
- 52W High
- $5.61
- 52W Low
- $0.26
- 50D MA
- $1.40
- 200D MA
- $1.40
- Beta
- -0.71
- RSI (14)
- 26
- Avg Volume
- 4.74M
No earnings-call transcripts are available for CJMB yet.
- Free Float
- 31.6%
- Shares Outstanding
- 4.78M
- Float Shares
- 1.51M
of shares held by institutions
15 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Creative Planning | 255.69K | 0 |
| Geode Capital Management, LLC | 203.64K | ▲ 187.97K |
| Jane Street Group, LLC | 42.50K | ▲ 42.50K |
| Vanguard Capital Management LLC | 28.22K | ▲ 21.56K |
| Vanguard Fiduciary Trust Co | 22.32K | ▲ 22.32K |
| Citadel Advisors LLC | 18.75K | ▼ 13.33K |
| Xtx Topco Ltd | 13.18K | ▲ 1.89K |
| Hightower Advisors, LLC | 12.50K | 0 |
| Qsemble Capital Management, LP | 7.16K | ▲ 5.60K |
| Ubs Group AG | 4.37K | ▼ 1.27K |
| Morgan Stanley | 2.73K | ▲ 2.73K |
| Tower Research Capital LLC (Trc) | 1.99K | ▲ 1.55K |
Held by 6 ETFs
Biggest fund positions in CJMB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 25 | Dial Gerald | buy | 10,000 |
| Mar 20, 26 | Croyle David J | buy | 10,195 |
| Mar 6, 26 | Croyle David J | buy | 14,805 |
| Feb 4, 25 | Dial Gerald | other | 25,000 |
| Dec 30, 25 | Dial Gerald | buy | 1,539 |
| Dec 30, 25 | Dial Gerald | buy | 461 |
| Dec 16, 25 | Williams Wayne D | buy | 5,000 |
| Dec 12, 25 | Williams Wayne D | buy | 4,926 |
| Dec 11, 25 | Williams Wayne D | buy | 62 |
| Dec 15, 25 | Williams Wayne D | buy | 10,810 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CJMB coverage
Recent articles, reports, and earnings notes.
No research on CJMB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CJMB report →Callan JMB CEO and Management Team Invest $1.5 Million in Common-Only Transaction at a Premium of $1.10 Per Share, Reinforcing Confidence in Growth Strategy
globenewswire.com · Nov 12
Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months
globenewswire.com · Nov 2
Callan JMB to Break Ground on IV Bag Manufacturing Facility Fully Funded by Non-Dilutive and Non-Interest-Bearing Third-Party Partnership
globenewswire.com · Oct 22
Callan JMB Advances IV Bag Manufacturing Facility with Projected $450 Million in Annual Revenue
globenewswire.com · Oct 20
Callan JMB Advances U.S. Pharmaceutical Manufacturing at the Atlas Complex and Expands into North American Equipment Distribution and Assembly
globenewswire.com · Oct 8
Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets
globenewswire.com · Aug 27
Callan JMB Designates Andy Weigman to Join Callan Power's Oil and Gas Development Efforts; Weigman Brings Experience on More Than $1 Billion in Sourced Acquisition Opportunities and Extensive Williston Basin Operational Expertise
globenewswire.com · Aug 25
Callan JMB Retains Northern Oil and Gas Founder Michael Reger as President of Callan Power; Northern Oil and Gas Now Valued at Approximately $2.9 Billion
globenewswire.com · Aug 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.